Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-03

Clinical Trial Update: Evaluation of Ciclo 21® Effect (Levonorgestrel + Ethinyl Estradiol) Compared to Nordette®. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Ciclo 21 (levonorgestrel/ethinyl estradiol) to Nordette for irregular periods has completed, sponsored by Azidus Brasil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciclo 21 (levonorgestrel/ethinyl estradiol)
  • Nordette (levonorgestrel/ethinyl estradiol)

Snippet

Sponsor: Azidus Brasil | Conditions: Irregular Periods | Phase 3 | Status: COMPLETED